Infectious episodes and hospitalization rates in the everolimus (EVR) group (n = 35 until month 24, n = 33 at month 36 and 48) and the control group (n = 70).

Data are given as median (range) or as percentage. P values were calculated by the $Wilcoxon test or by the §Fischer’s exact test. ARE, acute rejection episodes; EVR, everolimus; GI, GastrointestinalInfectious episodes and hospitalization rates in the everolimus (EVR) group (n = 35 until month 24, n = 33 at month 36 and 48) and the control group (n = 70).数据以中位数（极差）或百分比形式呈现。P值通过威尔科克森检验（Wilcoxon test）与费希尔精确检验（Fischer’s exact test）计算得到。其中，缩写定义如下：ARE为急性排斥反应发作（acute rejection episodes），EVR为依维莫司（everolimus），GI为胃肠道感染发作；本数据集统计了依维莫司组（EVR组，第24个月时样本量为35，第36、48个月时样本量为33）与对照组（样本量为70）的胃肠道感染发作情况及住院率。